Centogene_Logo.png
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
March 19, 2024 06:30 ET | Centogene NV
Longstanding global partnership provides an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 19, 2024 ...
Matrix Service Company Logo
Matrix Service Company Announces Strategic Relationship With Geldof to Provide Total EPC Solutions For Ammonia Storage Across Europe
March 19, 2024 06:30 ET | Matrix Service Company
Matrix Service Company announces strategic relationship with Geldof to provide total EPC solutions for ammonia storage across Europe.
Picture1.png
Corvette E-Ray with Carbon Revolution Wheels Wins The Drive’s Best Performance Car of 2023 Award
March 19, 2024 06:30 ET | Carbon Revolution Limited
Corvette E-Ray with Carbon Revolution Wheels Wins "The Drive’s" Best Performance Car of 2023 Award
Fennec logo.jpg
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
March 19, 2024 06:01 ET | Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...
BEAM-Logo-Color and Black-Large-576x375.png
Beam Global Granted U.S. Patent for Wireless / Inductive Electric Vehicle Charging Powered by Renewable Energy
March 19, 2024 06:00 ET | Beam Global
Beam Global Granted U.S. Patent for Wireless / Inductive Electric Vehicle Charging Powered by Renewable Energy
crinetics.png
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
March 19, 2024 06:00 ET | Crinetics Pharmaceuticals, Inc.
56% of Participants on Paltusotine Achieved IGF-1 ≤1.0 xULN vs. 5% on Placebo (p<0.0001) Paltusotine was Generally Well-tolerated with No Serious Adverse Events Positive Topline Results...
Unknown.jpg
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
March 19, 2024 06:00 ET | Opthea Limited
MELBOURNE, Australia and PRINCETON, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT; “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to...
Fespa-Max-Plus
Kornit Digital Reveals New Opportunities for Brands and Retailers, Sportswear, Home Décor, and Screen Printers with Robust Showcase at FESPA Digital Print Expo 2024
March 19, 2024 05:00 ET | Kornit Digital Ltd
Retailers and brands embrace new Kornit Atlas MAX PLUS, reinforcing the highest standards of quality, reliability, vibrant color matching, and unwavering consistency Preview of “Max Transfer,”...
XORTX Logo.jpg
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
March 19, 2024 05:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, March 19, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical...
pluri.jpg
Engage with Pluri's Talent: Exciting Conference Appearances Ahead
March 19, 2024 04:00 ET | Pluri Inc.
HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote...